发现了一种坦基拉酶支架抑制剂,专门针对ARC4结域
Chiara Bosetti1, Albert Galera-Prat1, Sven T Sowa1
1Faculty of Biochemistry and Molecular Medicine & Biocenter Oulu, University of Oulu, 90220 Oulu, Finland.
Structure (London, England : 1993)
|January 31, 2026
概括
研究人员确定了一种新的基于罗的化合物,可以选择性地抑制坦基拉酶ARC4.4. 这种有针对性的方法为涉及WNT/β-catenin通路的疾病提供了新的治疗策略.
科学领域:
- 生物化学 生化学
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 坦基酶是生物过程和疾病的关键调节者,特别是WNT/β-catenin通路.
- 目前的药物发现重点是抑制坦基拉酶催化活性.
- 通过tankyrase ARC域准蛋白质与蛋白质相互作用是一个新的治疗策略.
研究的目的:
- 使用基于FRET的测定方法选坦基拉酶ARC4域的抑制剂.
- 识别和描述选择性向ARC4.4的新型化合物.
- 探索ARC4特异性抑制的治疗潜力.
主要方法:
- 使用基于FRET的试验对EU-OPENSCREEN图书馆进行高通量选.
- 合成和表征基于皮罗隆的化合物,包括化合物S8 (ARCher-142).
- 核磁共振光谱学和X射线晶体学用于结合位点识别和选择性合理化.
主要成果:
- 发现以皮罗隆为基础的化合物作为ARC4抑制剂.
- 合成化合物S8 (ARCher-142) 与选择性结合ARC4 (8μM强度) 的合成.
- 通过结构分析确定结合地点和选择性的理由.
- 证明ARC4特异性抑制可以减弱细胞中的WNT/β-catenin信号传递.
结论:
- 针对单个坦基拉酶ARC域,特别是ARC4,是一种可行的治疗策略.
- 选择性ARC4抑制为调节WNT/β-catenin通路提供了量身定制的方法.
- 这项研究为开发针对性治疗针对涉及坦基拉斯的疾病提供了基础.
相关概念视频
01:52Eukaryotic Transcription Inhibitors
11.0K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.0K
02:26Conservation of Protein Domains Over Different Proteins
14.5K
Protein domains are small structurally independent units that are part of a single amino acid chain. Although these domains are often structurally independent, they may rely on synergistic effects to perform their functions as part of a larger protein. Protein domains may be conserved within the same organism, as well as across different organisms.
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to...
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to...
14.5K
01:49Conserved Binding Sites
5.2K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
5.2K
02:43Peptide Bonds
82.9K
A peptide bond covalently attaches amino acids through a dehydration reaction. One amino acid's carboxyl group and another amino acid's amino group combine, releasing a water molecule. The resulting bond is the peptide bond. The products that such linkages form are peptides. As more amino acids join this growing chain, the resulting chain is a polypeptide. Each polypeptide has a free amino group at one end. This end has the N-terminal, or the amino-terminal, and the other end has a free...
82.9K
02:18The Equilibrium Binding Constant and Binding Strength
15.0K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
15.0K
01:26Drug Discovery: Overview
11.6K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
11.6K